OÜ Asper Biolab (11538286)

OÜ Asper Biolab

Legal form:

Private limited company

Registry code:

11538286

VAT no.:

EE101257260

Fiscal-year period:

01.01 - 31.12

Established:

30.09.2008 (16)

Capital:

2 556 EUR

Address:

Tartu maakond, Tartu linn, Tartu linn, Vaksali tn 17a

Status:

Registered

Contacts

Email:

asper.biolab@asperbio.com

Industries

PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES
Activities of head offices and management consultancy activities
Management consultancy
7022 - Business and other management consultancy

VAT liability

	Start	End
EE101257260	29.09.2021
EE101257260	19.08.2009	24.10.2012
EE101257260	07.10.2008	25.01.2009

Annual reports

	Period	Submitted
2024	01.01.2024 - 31.12.2024	-
2023	01.01.2023 - 31.12.2023	09.07.2024	Valid
2022	01.01.2022 - 31.12.2022	26.06.2023	Valid
2021	01.01.2021 - 31.12.2021	30.06.2022	Valid
2020	01.01.2020 - 31.12.2020	25.06.2021	Valid
2019	01.01.2019 - 31.12.2019	29.10.2020	Valid
2018	01.01.2018 - 31.12.2018	29.06.2019	Valid
2017	01.01.2017 - 31.12.2017	19.06.2018	Valid
2016	01.01.2016 - 31.12.2016	11.05.2018	Valid
2015	01.01.2015 - 31.12.2015	27.06.2016	Valid
2014	01.01.2014 - 31.12.2014	27.05.2015	Valid
2013	01.01.2013 - 31.12.2013	30.06.2014	Valid
2012	01.01.2012 - 31.12.2012	29.05.2013	Valid
2011	01.01.2011 - 31.12.2011	12.06.2012	Valid
2010	01.01.2010 - 31.12.2010	09.08.2011	Valid
2009	30.09.2008 - 31.12.2009	29.06.2010	Valid

Unsubmitted declarations

✓ No unsubmitted declarations as of 17.06.2025.

Tax debt

✓ None

Unsubmitted reports

✓ Missing

Unsubmitted decl.

✓ Missing

Court decisions

Official notices

TTJA decisions

Real estate

.ee domains

Tax data

	State taxes	Taxable turnover	Employees
2025 Q1	330 €	1 500 €66.7%	-
Kokku 2025:	330 €	1 500 €
2024 Q4	990 €	4 500 €0.0%	-
2024 Q3	990 €	4 500 €0.0%	-
2024 Q2	990 €	4 500 €0.0%	-
2024 Q1	960 €	4 500 €0.0%	-
Kokku 2024:	3 930 €	18 000 €56.2%
2023 Q4	900 €	4 500 €0.0%	-
2023 Q3	900 €	4 500 €83.7%	-
2023 Q2	5 520 €	27 600 €513.3%	-
2023 Q1	0 €	4 500 €75.3%	-
Kokku 2023:	7 320 €	41 100 €52.6%
2022 Q4	1 998 €	18 225 €0.0%	-
2022 Q3	1 998 €	18 225 €43.0%	-
2022 Q2	3 096 €	31 950 €75.3%	-
2022 Q1	1 998 €	18 225 €1.7%	-
Kokku 2022:	9 090 €	86 625 €383.3%
2021 Q4	1 698 €	17 925 €	-
2021 Q3	0 €	0 €	-
Kokku 2021:	1 698 €	17 925 €

Revenue by industry

	2021	2022	2023
Business and other management consultancy		18 000 €	41 100 €
Research and development in biotechnology	41 175 €	68 625 €
Business consultancy and other management advice	18 000 €

Debts to the tax authority

✓ No tax debt as of 17.06.2025

2025 Q1

Turnover

Amount

1 500 €

Monthly average

500 €

Per employee

0 €

Equity ratio

19,56%

Labour taxes

Turnover ratio

0,00%

Tax ratio

0,00%

Monthly average

0 €

Per employee

0 €

State taxes

Monthly average

110 €

Turnover ratio

22,00%

Estimated salary

Gross salary

0 €

Net salary

0 €

Aggregate data

	2019	2020	2021	2022	2023
Current assets	43 249 €	16 498 €61.9%	8 693 €47.3%	6 781 €22.0%	6 839 €0.9%
Non-current assets	459 200 €	412 832 €10.1%	396 032 €4.1%	356 832 €9.9%	221 907 €37.8%
Varad kokku	502 449 €	429 330 €14.6%	404 725 €5.7%	363 613 €10.2%	228 746 €37.1%
Short-term liabilities	174 868 €	231 949 €32.6%	306 583 €32.2%	251 711 €17.9%	75 917 €69.8%
Pikaajalised kohustised	325 132 €	166 779 €48.7%	44 903 €73.1%	46 997 €4.7%	41 908 €10.8%
Kohustised kokku	500 000 €	398 728 €20.3%	351 486 €11.8%	298 708 €15.0%	117 825 €60.6%
Osa- või aktsiakapital	2 556 €	2 556 €0.0%	2 556 €0.0%	2 556 €0.0%	2 556 €0.0%
Jaotamata kasum	1 177 €	-107 €109.1%	28 046 €26 311.2%	50 683 €80.7%	62 349 €23.0%
Puhaskasum	-1 284 €	28 153 €2 292.6%	22 637 €19.6%	11 666 €48.5%	46 016 €294.4%
Omakapital	2 449 €	30 602 €1 149.6%	53 239 €74.0%	64 905 €21.9%	110 921 €70.9%
Turnover	-	28 300 €	59 175 €109.1%	86 625 €46.4%	41 100 €52.6%
Kasumimarginaal	0.00%	99.48%	38.25%61.5%	13.47%64.8%	111.96%731.4%

	Date of birth	Role	Start	Valid
Hardi Tamm	09.10.1974 (50)	Board member	19.11.2024	yes

	Birth or registration date	Role	Share	%	Type	Start
Korymbos OÜ	26.06.2013 (11)	Shareholder	2 556,00 EUR	100	Sole ownership	13.11.2024

	Date of birth	Control	Start
Hardi Tamm	09.10.1974 (50)	Indirect holding	29.10.2020
Katrin Tamm	11.05.1974 (51)	Indirect holding	07.09.2022

Holdings in companies

	Registered	Role	Share	%	Type	Start
Asper Biogene OÜ	24.05.2017	Shareholder	2 500,00 EUR	100	Sole ownership	02.09.2023
OÜ Genorama	30.09.2008	Shareholder	2 556,00 EUR	100	Sole ownership	02.09.2023

Regulations

	Date	Type	Deadline	Status
Ä 20042287 / 13	19.11.2024	Entry - Amendment entry		Entered into force (19.11.2024)
Ä 20042287 / M4	19.11.2024	Order to remedy deficiencies - Amendment entry	04.12.2024	Deficiencies remedied (19.11.2024)
Ä 20042287 / 12	13.11.2024	Entry - Amendment entry		Entered into force (13.11.2024)
Ä 20042287 / 11	12.11.2024	Entry - Amendment entry		Entered into force (12.11.2024)
Ä 20042287 / M3	12.11.2024	Order to remedy deficiencies - Amendment entry	13.12.2024	Deficiencies remedied (13.11.2024)
Ä 20042287 / M2	08.07.2024	Fine-warning order – annual report not filed	07.08.2024	Deficiencies remedied (10.07.2024)
Ä 20042287 / 10	02.09.2023	Entry - Amendment entry		Entered into force (02.09.2023)
Ä 20042287 / 9	29.10.2020	Entry - Amendment entry		Entered into force (29.10.2020)
Ä 20042287 / 8	02.12.2019	Entry - Amendment entry		Entered into force (02.12.2019)
Ä 20042287 / 7	19.06.2018	Entry - Amendment entry		Entered into force (19.06.2018)
Ä 20042287 / M1	11.05.2018	Warning for deletion from register – annual report not filed	12.11.2018	Deficiencies remedied (11.05.2018)
Ä 20042287 / 6	18.01.2018	Entry - Amendment entry		Entered into force (18.01.2018)
Ä 20042287 / 5	22.12.2017	Entry - Amendment entry		Entered into force (22.12.2017)
Ä 20042287 / 4	04.12.2017	Entry - Amendment entry		Entered into force (04.12.2017)
Ä 20042287 / 3	11.08.2010	Entry - Amendment entry		Entered into force (11.08.2010)
Ä 20042287 / 2	25.06.2010	Entry - Amendment entry under CRA § 525 (2)		Entered into force (25.06.2010)
Ä 42287	30.09.2008	Entry - Initial entry		Entered into force (30.09.2008)